<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Differential diagnosis of Parkinson disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Differential diagnosis of Parkinson disease</h1>
<div class="graphic"><div class="figure"><div class="ttl">Differential diagnosis of Parkinson disease</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Category</td> <td class="subtitle1">Disorder</td> <td class="subtitle1">Pathophysiology</td> <td class="subtitle1">Core clinical features</td> <td class="subtitle1">Clues and distinguishing features from PD</td> </tr> <tr> <td><strong>Prominent tremor</strong></td> <td>Essential tremor</td> <td>Not well characterized</td> <td> <ul> <li>Bilateral action tremor in upper extremities</li> <li>Often also involves head and/or voice</li> </ul> </td> <td> <ul> <li>Tremor is not present at rest (unless tremor is severe)</li> <li>No involvement of face or legs</li> <li>Family history</li> <li>Relieved by alcohol</li> </ul> </td> </tr> <tr> <td rowspan="4"><strong>Atypical parkinsonian disorders</strong></td> <td>Dementia with Lewy bodies</td> <td>Synucleinopathy</td> <td> <ul> <li>Dementia</li> <li>Visual hallucinations</li> <li>Fluctuating cognition</li> <li>Parkinsonism</li> </ul> </td> <td> <ul> <li>Dementia begins before or at the same time as motor symptoms</li> </ul> </td> </tr> <tr> <td>Multiple system atrophy</td> <td>Synucleinopathy; oligodendroglial alpha-synuclein aggregation</td> <td> <ul> <li>Parkinsonism and/or cerebellar dysfunction</li> <li>Autonomic failure</li> <li>Pyramidal signs</li> </ul> </td> <td> <ul> <li>Poor response to levodopa</li> <li>Symmetric motor symptoms</li> <li>Early falls</li> <li>Relatively preserved cognitive function</li> <li>Nocturnal stridor</li> </ul> </td> </tr> <tr> <td>Progressive supranuclear palsy</td> <td>Tauopathy; tau-positive deposits in neurons and glia of basal ganglia, brainstem, cerebellum, and cortex</td> <td> <ul> <li>Gait disturbance with falls</li> <li>Ophthalmoparesis</li> <li>Parkinsonism</li> </ul> </td> <td> <ul> <li>Poor response to levodopa</li> <li>Early falls</li> <li>No tremor</li> <li>Pseudobulbar affect</li> </ul> </td> </tr> <tr> <td>Corticobasal degeneration</td> <td>Tauopathy; tau-positive deposits in neurons and glia of cortex and striatum</td> <td> <ul> <li>Asymmetric movement disorder (limb rigidity, dystonia, and/or myoclonus)</li> <li>Orobuccal or limb apraxia</li> <li>Cortical sensory deficits</li> <li>Alien limb phenomenon</li> <li>Cognitive dysfunction</li> </ul> </td> <td> <ul> <li>Poor response to levodopa</li> <li>Aphasia, apraxia, and cortical sensory loss</li> </ul> </td> </tr> <tr> <td class="border_bottom_thick" rowspan="4"><strong>Other neurodegenerative disorders</strong></td> <td>Idiopathic and familial basal ganglia calcification</td> <td>Calcium deposits in basal ganglia; multiple causative genes</td> <td> <ul> <li>Parkinsonism</li> <li>Chorea</li> <li>Dystonia</li> <li>Cognitive impairment</li> <li>Ataxia</li> </ul> </td> <td> <ul> <li>Basal ganglia calcification on CT</li> <li>Family history (autosomal dominant or recessive pattern)</li> </ul> </td> </tr> <tr> <td>Huntington disease</td> <td>CAG repeat expansion in the <em>HTT</em> gene; toxic gain-of-function mechanism due to mutant huntingtin protein</td> <td> <ul> <li>Chorea</li> <li>Psychiatric illness</li> <li>Dementia</li> <li>Parkinsonism more common with older age of onset</li> </ul> </td> <td> <ul> <li>Abnormal eye movements</li> <li>Motor impersistence</li> <li>No tremor</li> <li>Family history</li> </ul> </td> </tr> <tr> <td>Frontotemporal dementia with parkinsonism</td> <td>Tauopathy; pathogenic variant in the <em>MAPT</em> gene on chromosome 17</td> <td> <ul> <li>Frontotemporal dementia (usually behavioral variant)</li> <li>Parkinsonism</li> </ul> </td> <td> <ul> <li>Family history (autosomal dominant pattern)</li> <li>Younger age of onset</li> <li>Early memory impairment</li> </ul> </td> </tr> <tr class="border_bottom_thick"> <td>Spinocerebellar ataxia</td> <td>&gt;40 genetic causes</td> <td> <ul> <li>Progressive cerebellar syndrome</li> <li>Variable oculomotor, retinal, pyramidal, extrapyramidal, sensory, and cognitive symptoms depending on gene defect</li> </ul> </td> <td> <ul> <li>Younger age of onset</li> <li>Family history</li> </ul> </td> </tr> <tr> <td class="subtitle1_left_white" rowspan="8">Secondary parkinsonism</td> <td class="subtitle1_left">Causes</td> <td class="subtitle1_left" colspan="3">Examples</td> </tr> <tr> <td>Drug-induced</td> <td colspan="3">Antipsychotic agents, metoclopramide, prochlorperazine, tetrabenazine, valproic acid</td> </tr> <tr> <td>Vascular</td> <td colspan="3">Vascular parkinsonism, vascular dementia</td> </tr> <tr> <td>Toxic</td> <td colspan="3">Carbon disulfide, carbon monoxide, cyanide, MPTP, manganese, organic solvents</td> </tr> <tr> <td>Metabolic</td> <td colspan="3">Hypoparathyroidism, pseudohypoparathyroidism, chronic liver failure, extrapontine myelinolysis, end-stage kidney disease with diabetes, type 2 diabetes</td> </tr> <tr> <td>Structural</td> <td colspan="3">Normal pressure hydrocephalus, chronic subdural hematoma, tumors involving striatonigral circuits, head trauma</td> </tr> <tr> <td>Infectious</td> <td colspan="3">Encephalitis lethargica, HIV/AIDS, neurosyphilis, prion disease, progressive multifocal leukoencephalopathy, toxoplasmosis</td> </tr> <tr> <td>Genetic</td> <td colspan="3">Wilson disease, neurodegeneration with brain iron accumulation, neuroacanthocytosis</td> </tr> </tbody></table></div><div class="graphic_footnotes">PD: Parkinson disease; CT: computed tomography; CAG: cytosine-adenine-guanine; <em>HTT</em>: huntingtin; <em>MAPT</em>: microtubule associated protein tau; MPTP: 1-methyl-phenyl-1,2,3,6-tetrahydropyridine; HIV: human immunodeficiency virus; AIDS: acquired immunodeficiency syndrome.</div><div id="graphicVersion">Graphic 141072 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
